Saint-Hyacinthe – Quebec. Local success story Trans-America Genetics L.P. (“TAG”) announced today that its Canadian semen sales increased 51% in the quarter ending March 31, 2014. Company officials also confirmed continuing confidence and support from its key creditor and its partners as part of an ongoing refocusing plan of business priorities.
After a lackluster 2013, management of TAG is pleased to announce that it has continued to execute on its refocusing plan, thereby generating a 51% increase in sales of semen in the Canadian market for the first three months of the year. Patrice Simard, President of TAG, declared “TAG’s key creditor, partners and dairy breeders clients have shown strong continued support for the TAG enterprise and its products, and we will continue to deliver on the market’s high expectations. Working closely with our partners has clearly paid off, as demonstrated by TAG recently releasing the exciting new sire Mr. Donalynn MILLENNIUM for general usage. MILLLENNIUM combines Extreme Type, both at CDN and USDA Systems, with a +20 in Type and +4.07 GPTAT. This TAG star is believed to be one of the very best in the industry at this time. We expect great things from MILLENNIUM and we recognize and appreciate the community’s continued confidence”.
TAG also confirmed it has received strong confidence and support from the Tactex F1 Private Equity Fund LP, (“F1 Fund”), it’s largest creditor. Richard Ness of the F1 Fund was recently quoted: “Our Fund recognizes the long term potential of TAG and the technical strengths and vision of its management team, and we have taken meaningful action to promote the firm’s continued success, including our full support and expertize in order to allow the firm to grow unburdened and generally protect its interest in the most cost effective manner possible”.
Trans-America Genetics is specialized in genetic and marketing strategies for Holstein, Jersey and Ayrshire markets across the globe. Trans-America Genetics is a North America based company and focuses in identifying and marketing elite dairy genetics to international markets. TAG was founded in July 2008. For more information, please visit http://www.transamericagenetics.com
Tactex F1 Private Equity Fund L.P.
The Tactex F1 Private Equity Fund focuses on direct investments in cash flow positive, small-cap entities or start-up firms through a combination of debt, preferred shares, or common shares with the intent to create long-term value. Tactex’ investment philosophy is governed by the belief that value can be created through direct involvement in management or through funding where cash-flow requirements can improve competitive positioning. For more information, please visit https://www.tactex.ca/web/guest/tactex-f1-private-equity-fund-lp